The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Disruptive Behavior Disorders (DBD) Market Research Report 2025
Synopsis
Disruptive Behavior Disorders (DBD) is behavioral disorders characterized by hostile and defiant behaviors that children and adolescents direct towards others.
The global Disruptive Behavior Disorders (DBD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global disruptive behavior disorders market is being driven by the rise in the number of comorbid disorders, active involvement of NGO and government programs to increase awareness.
This report aims to provide a comprehensive presentation of the global market for Disruptive Behavior Disorders (DBD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Disruptive Behavior Disorders (DBD).
Report Scope
The Disruptive Behavior Disorders (DBD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Disruptive Behavior Disorders (DBD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Disruptive Behavior Disorders (DBD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Bionomics
Chelsea Therapeutics
Pfizer
Johnson & Johnson
DURECT
Novartis
McNeil Pharmaceuticals
Sunovion Pharmaceuticals
New River Pharmaceuticals
Segment by Type
Stimulants
Non-stimulants
Segment by Application
Conduct Disorder (CD)
Oppositional Defiant Disorder (ODD)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Disruptive Behavior Disorders (DBD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Disruptive Behavior Disorders (DBD) is behavioral disorders characterized by hostile and defiant behaviors that children and adolescents direct towards others.
The global Disruptive Behavior Disorders (DBD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global disruptive behavior disorders market is being driven by the rise in the number of comorbid disorders, active involvement of NGO and government programs to increase awareness.
This report aims to provide a comprehensive presentation of the global market for Disruptive Behavior Disorders (DBD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Disruptive Behavior Disorders (DBD).
Report Scope
The Disruptive Behavior Disorders (DBD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Disruptive Behavior Disorders (DBD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Disruptive Behavior Disorders (DBD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Bionomics
Chelsea Therapeutics
Pfizer
Johnson & Johnson
DURECT
Novartis
McNeil Pharmaceuticals
Sunovion Pharmaceuticals
New River Pharmaceuticals
Segment by Type
Stimulants
Non-stimulants
Segment by Application
Conduct Disorder (CD)
Oppositional Defiant Disorder (ODD)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Disruptive Behavior Disorders (DBD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Disruptive Behavior Disorders (DBD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stimulants
1.2.3 Non-stimulants
1.3 Market by Application
1.3.1 Global Disruptive Behavior Disorders (DBD) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Conduct Disorder (CD)
1.3.3 Oppositional Defiant Disorder (ODD)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Disruptive Behavior Disorders (DBD) Market Perspective (2019-2030)
2.2 Disruptive Behavior Disorders (DBD) Growth Trends by Region
2.2.1 Global Disruptive Behavior Disorders (DBD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Disruptive Behavior Disorders (DBD) Historic Market Size by Region (2019-2024)
2.2.3 Disruptive Behavior Disorders (DBD) Forecasted Market Size by Region (2025-2030)
2.3 Disruptive Behavior Disorders (DBD) Market Dynamics
2.3.1 Disruptive Behavior Disorders (DBD) Industry Trends
2.3.2 Disruptive Behavior Disorders (DBD) Market Drivers
2.3.3 Disruptive Behavior Disorders (DBD) Market Challenges
2.3.4 Disruptive Behavior Disorders (DBD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Disruptive Behavior Disorders (DBD) Players by Revenue
3.1.1 Global Top Disruptive Behavior Disorders (DBD) Players by Revenue (2019-2024)
3.1.2 Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Players (2019-2024)
3.2 Global Disruptive Behavior Disorders (DBD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Disruptive Behavior Disorders (DBD) Revenue
3.4 Global Disruptive Behavior Disorders (DBD) Market Concentration Ratio
3.4.1 Global Disruptive Behavior Disorders (DBD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Disruptive Behavior Disorders (DBD) Revenue in 2023
3.5 Disruptive Behavior Disorders (DBD) Key Players Head office and Area Served
3.6 Key Players Disruptive Behavior Disorders (DBD) Product Solution and Service
3.7 Date of Enter into Disruptive Behavior Disorders (DBD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Disruptive Behavior Disorders (DBD) Breakdown Data by Type
4.1 Global Disruptive Behavior Disorders (DBD) Historic Market Size by Type (2019-2024)
4.2 Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Type (2025-2030)
5 Disruptive Behavior Disorders (DBD) Breakdown Data by Application
5.1 Global Disruptive Behavior Disorders (DBD) Historic Market Size by Application (2019-2024)
5.2 Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Disruptive Behavior Disorders (DBD) Market Size (2019-2030)
6.2 North America Disruptive Behavior Disorders (DBD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Disruptive Behavior Disorders (DBD) Market Size by Country (2019-2024)
6.4 North America Disruptive Behavior Disorders (DBD) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Disruptive Behavior Disorders (DBD) Market Size (2019-2030)
7.2 Europe Disruptive Behavior Disorders (DBD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Disruptive Behavior Disorders (DBD) Market Size by Country (2019-2024)
7.4 Europe Disruptive Behavior Disorders (DBD) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size (2019-2030)
8.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Region (2019-2024)
8.4 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Disruptive Behavior Disorders (DBD) Market Size (2019-2030)
9.2 Latin America Disruptive Behavior Disorders (DBD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Disruptive Behavior Disorders (DBD) Market Size by Country (2019-2024)
9.4 Latin America Disruptive Behavior Disorders (DBD) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size (2019-2030)
10.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Country (2019-2024)
10.4 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Disruptive Behavior Disorders (DBD) Introduction
11.1.4 Eli Lilly Revenue in Disruptive Behavior Disorders (DBD) Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 Bionomics
11.2.1 Bionomics Company Detail
11.2.2 Bionomics Business Overview
11.2.3 Bionomics Disruptive Behavior Disorders (DBD) Introduction
11.2.4 Bionomics Revenue in Disruptive Behavior Disorders (DBD) Business (2019-2024)
11.2.5 Bionomics Recent Development
11.3 Chelsea Therapeutics
11.3.1 Chelsea Therapeutics Company Detail
11.3.2 Chelsea Therapeutics Business Overview
11.3.3 Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Introduction
11.3.4 Chelsea Therapeutics Revenue in Disruptive Behavior Disorders (DBD) Business (2019-2024)
11.3.5 Chelsea Therapeutics Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Disruptive Behavior Disorders (DBD) Introduction
11.4.4 Pfizer Revenue in Disruptive Behavior Disorders (DBD) Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Disruptive Behavior Disorders (DBD) Introduction
11.5.4 Johnson & Johnson Revenue in Disruptive Behavior Disorders (DBD) Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 DURECT
11.6.1 DURECT Company Detail
11.6.2 DURECT Business Overview
11.6.3 DURECT Disruptive Behavior Disorders (DBD) Introduction
11.6.4 DURECT Revenue in Disruptive Behavior Disorders (DBD) Business (2019-2024)
11.6.5 DURECT Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Disruptive Behavior Disorders (DBD) Introduction
11.7.4 Novartis Revenue in Disruptive Behavior Disorders (DBD) Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 McNeil Pharmaceuticals
11.8.1 McNeil Pharmaceuticals Company Detail
11.8.2 McNeil Pharmaceuticals Business Overview
11.8.3 McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
11.8.4 McNeil Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2019-2024)
11.8.5 McNeil Pharmaceuticals Recent Development
11.9 Sunovion Pharmaceuticals
11.9.1 Sunovion Pharmaceuticals Company Detail
11.9.2 Sunovion Pharmaceuticals Business Overview
11.9.3 Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
11.9.4 Sunovion Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2019-2024)
11.9.5 Sunovion Pharmaceuticals Recent Development
11.10 New River Pharmaceuticals
11.10.1 New River Pharmaceuticals Company Detail
11.10.2 New River Pharmaceuticals Business Overview
11.10.3 New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
11.10.4 New River Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2019-2024)
11.10.5 New River Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
